Breaking News, Financial News

4Q Financials: AMRI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 4Q Revenue: $39.1 million (-15%) 4Q Loss: $942 thousand (earnings were $3.4 million 4Q2004) FY Revenue: $183.9 million (+8%) FY Earnings: $16.3 million (loss of $11.7 million FY2004) Comments: Contract revenue from discovery services in the quarter was $8.3 million, up 18%. Contract revenue from development and small scale manufacturing services in the quarter was $7.5 million, up 19%. Contract revenue from large scale manufacturing in the quarter was $17.1 million, down...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters